Evidence map›Paper›PMID 34627270›Full record

ArticleLipids in health and disease2021

Association of lipid accumulation product with chronic kidney disease in Chinese community adults: a report from the REACTION study.

Pijun Yan, Yong Xu, Ying Miao, Qian Tang, Yuru Wu, Xue Bai, Zhihong Zhang, Qian Li, Qin Wan

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Lipids in health and disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Pijun YanDepartment of Endocrinology, the Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China.ORCID http://orcid.org/0000-0001-6692-2401
Yong XuDepartment of Endocrinology, the Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China.
Ying MiaoDepartment of Endocrinology, the Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China.
Qian TangDepartment of Endocrinology, the Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China.
Yuru WuDepartment of Endocrinology, the Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China.
Xue BaiDepartment of Endocrinology, the Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China.
Zhihong ZhangDepartment of General Medicine, the Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China.
Qian LiSouthwest Medical University, Luzhou, 646000, Sichuan, China.
Qin WanDepartment of Endocrinology, the Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China. wanqin231@126.com.
Affiliated Hospital of Southwest Medical University · CNSouthwest Medical University · CN

Funding

grants from the National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology 2012ZX09303006-001
6 · The paper itself

Abstract

backgroundLimited studies regarding the correlation of lipid accumulation product (LAP) with a decreased estimated glomerular filtration rate (eGFR) have yielded conflicting findings, and no report has demonstrated the relationship of LAP with chronic kidney disease (CKD), defined as the presence of albuminuria and/or a decreased eGFR. The purpose of this study was to estimate the possible correlation of LAP with CKD prevalence in Chinese community adults.

methodIn this cross-sectional study, LAP level of 7202 participants (age ≥ 40 years) was determined, and its possible association with CKD was evaluated by a multiple logistic regression model.

resultsCompared with subjects with non-CKD, non-albuminuria, and high eGFR, LAP levels significantly increased in female not male subjects with CKD, albuminuria, and low eGFR, respectively (all P < 0.001). The univariate logistic regression analysis revealed that LAP level of female not male subjects were significantly and positively associated with the prevalence of CKD (P < 0.001). The multivariate logistic regression analysis showed that the risk of CKD prevalence in female not male subjects progressively increased across LAP quartiles (P for trend < 0.01), and the risk of CKD prevalence of subjects in Q4 significantly increased compared to those in Q1 after adjustment for potential confounding factors in Models 4 (odds ratio [OR]: 1.382, 95% confidence intervals [CI] 1.002-1.906, P < 0.05). Stratified analysis revealed positive associations of LAP quartiles with risk of CKD prevalence in people with the following characteristics: women, older, overweight, with hypertension, normal glucose tolerance, appropriate low-density lipoprotein cholesterol, nonsmokers, nondrinkers, and no cardiovascular disease events.

conclusionsHigh LAP levels might be significantly associated with risk of CKD prevalence in community-dwelling Chinese female adults, which may inform both public health recommendations and clinical practice.

Indexed as

Lipid Accumulation ProductOverweightAdultAgedAlbuminuriaAsian PeopleChinaCross-Sectional StudiesFemaleGlomerular Filtration RateHumansHypertensionMaleMiddle AgedPrevalenceRenal Insufficiency, ChronicAlbuminuriaChinese community adultsChronic kidney diseaseEstimated glomerular filtration rateLipid accumulation productStratified analysisVisceral obesity

Identifiers

PMID34627270
PMCPMC8502407
OpenAlexW3134796082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.